Search research articles
Contact Us
Filters
Showing results (21-30 of 25) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 25 results.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
September 22, 2017
A common haplotype containing functional CACNA1H variants is frequently coinherited with increased TPSAB1 copy number
Jonathan J Lyons, Stephanie C Stotz, Jack Chovanec, et al.
Atherosclerosis
|
December 1, 2022
Epigenetic BET reader inhibitor apabetalone (RVX-208) counters proinflammatory aortic gene expression in a diet induced obesity mouse model and in human endothelial cells
Sylwia Wasiak, Laura M Tsujikawa, Emily Daze, et al.
Clinical Epigenetics
|
November 11, 2020
BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes
Sylwia Wasiak, Kim E Dzobo, Brooke D Rakai, et al.
Translational Neuroscience
|
January 15, 2024
The BET inhibitor apabetalone decreases neuroendothelial proinflammatory activation <i>in vitro</i> and in a mouse model of systemic inflammation
Sylwia Wasiak, Li Fu, Emily Daze, et al.
Clinical Epigenetics
|
July 14, 2019
Apabetalone (RVX-208) reduces vascular inflammation in vitro and in CVD patients by a BET-dependent epigenetic mechanism
Laura M Tsujikawa, Li Fu, Shovon Das, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 25) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 25 results.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
September 22, 2017
A common haplotype containing functional CACNA1H variants is frequently coinherited with increased TPSAB1 copy number
Jonathan J Lyons, Stephanie C Stotz, Jack Chovanec, et al.
Atherosclerosis
|
December 1, 2022
Epigenetic BET reader inhibitor apabetalone (RVX-208) counters proinflammatory aortic gene expression in a diet induced obesity mouse model and in human endothelial cells
Sylwia Wasiak, Laura M Tsujikawa, Emily Daze, et al.
Clinical Epigenetics
|
November 11, 2020
BET protein inhibitor apabetalone (RVX-208) suppresses pro-inflammatory hyper-activation of monocytes from patients with cardiovascular disease and type 2 diabetes
Sylwia Wasiak, Kim E Dzobo, Brooke D Rakai, et al.
Translational Neuroscience
|
January 15, 2024
The BET inhibitor apabetalone decreases neuroendothelial proinflammatory activation <i>in vitro</i> and in a mouse model of systemic inflammation
Sylwia Wasiak, Li Fu, Emily Daze, et al.
Clinical Epigenetics
|
July 14, 2019
Apabetalone (RVX-208) reduces vascular inflammation in vitro and in CVD patients by a BET-dependent epigenetic mechanism
Laura M Tsujikawa, Li Fu, Shovon Das, et al.
Page
of 3